Journal: Atherosclerosis

Article Title: Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.

PMID/MRN: 27816804

Publication Date: 2016-Dec-07

Abstract:

Effects of single ascending doses of MDCO-216 on plasma lipid and lipoprotein levels were assessed in human healthy volunteers and in patients with stable coronary artery disease (CAD). MDCO-216 was infused at a single dose of 5, 10, 20, 30 or 40Êmg/kg over 2Êh and blood was collected at 2, 4, 8, 24, 48, 168 and 720Êh after start of infusion (ASOI). Lipoprotein lipids were assessed by FLPC and by 1H NMR. Plasma concentrations of free cholesterol (FC) displayed a rapid and dose-dependent rise, peaking at 8Êh, but remaining above baseline until 48Êh ASOI, whereas levels of esterified cholesterol (CE) increased at lower doses but not at higher doses, and even decreased below baseline at the highest dose. Plasma cholesterol esterification rate (CER) decreased with a first nadir between 4 and 8Êh and a second nadir at 48Êh ASOI. Taken over all subjects receiving MDCO-216, the increase in FC at 8Êh correlated inversely with the drop in CER at 4Êh but positively with the increase in basal and scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux capacities at 2Êh ASOI. Upon FPLC analysis, FC was found to increase first in high density lipoproteins (HDL) and very low density lipoproteins (VLDL) and later (at 48 or 168Êh ASOI) in low density lipoproteins (LDL). CE initially decreased in LDL and HDL but after 24Êh started to increase in VLDL and LDL whereas HDL-CE was still below baseline at 48Êh. Phospholipids (PL) showed the same pattern as FC. Triglycerides (TG) also rose rapidly, most prominently in VLDL, but also in LDL and HDL. Apolipoprotein E (Apo-E) in VLDL increased at 4-8Êh but returned to baseline at 24Êh ASOI. 1H NMR analysis showed a rapid and dose-dependent increase in HDL particle size, peaking at 2Êh and returning to baseline at 24Êh, and a small increase in HDL particle concentration. After infusion of the 40Êmg/kg dose, LDL and VLDL-particles also increased in number and size. A single administration of MDCO-216 caused rapid changes in lipid levels and lipoprotein composition, some of which persisted for at least 7 days. Copyright å© 2016 Elsevier Ireland Ltd. All rights reserved.